On July 29, 2024, the OtarBioPharm biopharmaceutical plant was visited by Sultangaziyev T.S. – First Vice-Minister of Health of the Republic of Kazakhstan, Ahmed-Zaki D.Zh. – Vice-Minister of Science and Higher Education of the Republic of Kazakhstan, Kalenderov N.S. – First Deputy Akim of Zhambyl region, Sadvakasov N.O. – Chairman of the Committee of Sanitary andepidemiological control of the Ministry of Health, Kinayatov A.K. – Director of the Department of Development of the Pharmaceutical and Medical Industry of the Ministry of Health, Orumbayev E.K. – Head of the Construction Department of the Akimat of Zhambyl region, Ospanova Zh.M. – Head of the Health Department of the Akimat of Zhambyl region, Kurmanaly H. – Assistant to the first deputy akim of Zhambyl region, Mukhamedieva D.M. – Chief expert of the Committee of Science of the Ministry of Internal Affairs, Abduraimov Ye.O. – General Director of JSC “National Holding “QazBioPharm”, Rsaliyev A.S. – Deputy General Director of JSC “National Holding “QazBioPharm”, Bekshin Zh.M. – General Director of LLP “Republican collection of microorganisms”, Ogai V.B. – General Director of the National Center of Biotechnology LLP (NCB), Skiba Yu.A. – Head of the Almaty branch of the NCB, Ostapchuk Ye.O. – Head of the Laboratory of Immunology and Immunobiotechnology, Sadanov A.K. – General Director of the Scientific and Production Center of Microbiology and Virology LLP (SPCMV), Baimakhanova B.B. – Deputy General Director of SPCMV, Tolokonnikov Ye.G. – Director of the Karaganda Pharmaceutical Plant, Sharipov K.O. – General Director of the Institute of Molecular Biology and Biochemistry named after M.A. Aitkhozhin, G.S. Zhunusova – Director of the Institute of Genetics and Physiology, Zhenis Zh. – Director of the Research Center of Medicinal Plants of the Al-Farabi Kazakh National University.

The General Director of OtarBioPharm LLP, Z. Yershebulov, presented to the visitors the second production complex – a workshop for the production of active substances, then a production line and laboratories of a biopharmaceutical plant for the production of immunobiological drugs.

Further, after getting acquainted with the activities of the biopharmaceutical plant,
issues of the development of biopharmaceutical science and industry were discussed.